UNSPSC 51292902: Clomipramine

This classification denotes a tricyclic antidepressant with the molecular formula C19H23ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NUV44L116D, chemically known as 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5h-dibenz(b,f)azepine but generally known as clomipramine, which bears US NIH Compound Identifier 2801. European Medicines Agency schedules Clomipramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06725MIG.

UNSPSC 51292902 Clomipramine is a Commodity code that nominally covers a single pharmaceutical product, but the recent state and local opportunities tagged under this code reveal a significant mismatch: the solicitations actual procurement covers naloxone, safe drug deactivation systems, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products — none of which are clomipramine. The code shows little relevant recent activity aligned with its nominal scope. State and local purchasing offices are using this code to tag pharmaceutical procurement opportunities more broadly, suggesting either taxonomic drift in how jurisdictions apply the Commodity code or misclassification in the opportunity tagging process. The issuing bodies span county public health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance).

Geographic activity appears concentrated in the South and Upper Midwest, with recent opportunities posted from Florida, Texas, and Minnesota. Seminole County issued an IFB (IFB60459723LAS) due July 26, 2023, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Texas HHS posted an RFI (HHS0017013) in early April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers to participating state and local government facilities. Business development professionals evaluating this code should treat the taxonomic misalignment as a signal to verify UNSPSC coding against actual scope language in posted solicitations rather than relying on the Commodity code name alone.